VRUS (VRUS) Stock Price & Analysis
VRUS (VRUS) rose 0.00% to USD 0 as of June 10, 2026 at 05:06 UTC, according to Nexqual real-time market data.
VRUS last closed at USD 0; the session ranged USD 0–0 on volume of 27,038 shares. Market capitalization is $202,451, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 05:06 UTC.
Key Statistics (as of June 10, 2026 at 05:06 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 27,038 shares |
| Market Cap | $202,451 |
| Exchange | PNK |
Technical Analysis (VRUS)
Nexqual's technical model rates VRUS "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 05:06 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (VRUS)
Wall Street analysts rate VRUS "None", per Nexqual as of June 10, 2026 at 05:06 UTC.
| Consensus Rating | None |
|---|
Earnings (VRUS)
Source: Nexqual, June 10, 2026 at 05:06 UTC.
Financials & Fundamentals (VRUS)
| Total Revenue | $105,289 |
|---|---|
| Gross Margin | +72.96% |
| Operating Margin | -1254.29% |
| Profit Margin | +0.00% |
| Current Ratio | 0.09 |
| Total Cash | $21,678 |
| Total Debt | $1.65M |
| Free Cash Flow | $3.11M |
Source: Nexqual, June 10, 2026 at 05:06 UTC.
Financial Health Score (VRUS)
Nexqual rates VRUS's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:06 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $22K cash vs $2M debt |
| Cash Flow | Strong — FCF $3M, 54% margin |
| Efficiency | Mixed — No data |
Ownership (VRUS)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.02B |
| Float | 2.02B |
Source: Nexqual, June 10, 2026 at 05:06 UTC.
Leadership (VRUS)
VRUS is led by Wendi Stevens, Vice President of Sales & Operations, per Nexqual as of June 10, 2026 at 05:06 UTC.
| Vice President of Sales & Operations | Wendi Stevens |
|---|---|
| Chief Technology Officer | Julio Fernandez |
| President of Medical Supply Division | Anders Gratte |
| President of Real Estate Operations | Alex O. Aliksanyan (age 74) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TTCM | Tautachrome Inc. | USD 0 | ▲ 0% |
| TPTW | TPT Global Tech, Inc. | USD 0 | ▲ 0% |
| VYST | Vystar Corp. | USD 0.16 | ▲ 6.27% |
| BBRW | BREWBILT MFG INC. | USD 0 | ▲ 0% |
| AXXA | Exxe Group Inc. | USD 0 | ▼ 20% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:06 UTC. This page is informational and not investment advice.